Recent Comments

Comment RSS

Spinal Cord Injury News and Research RSS Feed - Spinal Cord Injury News and Research

A spinal cord injury usually begins with a sudden, traumatic blow to the spine that fractures or dislocates vertebrae. The damage begins at the moment of injury when displaced bone fragments, disc material, or ligaments bruise or tear into spinal cord tissue. Most injuries to the spinal cord don't completely sever it. Instead, an injury is more likely to cause fractures and compression of the vertebrae, which then crush and destroy the axons, extensions of nerve cells that carry signals up and down the spinal cord between the brain and the rest of the body. An injury to the spinal cord can damage a few, many, or almost all of these axons. Some injuries will allow almost complete recovery. Others will result in complete paralysis.

New mathematical model may hasten drug development for Parkinson's Disease

19. November 2009 01:52
Australian scientists have significantly advanced our understanding of dopamine release from nerve cells, findings that should speed the development of more effective drugs for treating Parkinson's Disease. [More]

Neuralstem provides financial and business updates for third-quarter 2009

17. November 2009 08:30
Neuralstem, Inc. today provided a financial and business update for the third quarter ended September 30, 2009. [More]

Researchers discover a way to boost levels of palmitoylethanolamide

17. November 2009 04:28
UC Irvine pharmacology researchers have discovered a way to boost levels of a natural body fat that helps decrease inflammation, pointing to possible new treatments for allergies, illnesses and injuries related to the immune system. [More]

Posted in: Medical Science News

Tags: , , , ,

Transplantation of hESC-derived OPCs spare spinal cord tissue in the cervical lesion site: Study

12. November 2009 03:47
Geron Corporation today announced the publication of data showing that oligodendrocyte progenitor cells (OPCs) derived from human embryonic stem cells (hESCs), when transplanted into a rodent model of cervical spinal cord injury, reduced tissue damage within the lesion and improved recovery of locomotor function. [More]

FDA approved stem cell therapy restores limb function in rats with neck spinal cord injuries

10. November 2009 01:02
The first human embryonic stem cell treatment approved by the FDA for human testing has been shown to restore limb function in rats with neck spinal cord injuries - a finding that could expand the clinical trial to include people with cervical damage. [More]

New approach for repairing damaged nerve fibers in spinal cord injuries using nano-spheres discovered

9. November 2009 00:16
Researchers at Purdue University have discovered a new approach for repairing damaged nerve fibers in spinal cord injuries using nano-spheres that could be injected into the blood shortly after an accident. [More]

FDA extends review date of New Drug Application for GSK1838262/XP13512

7. November 2009 01:31
GlaxoSmithKline and XenoPort, Inc. (Nasdaq: XNPT) today announced that the U.S. Food and Drug Administration (FDA) has extended the original Prescription Drug User Fee Act (PDUFA) goal date for its review of the New Drug Application (NDA) for GSK1838262/XP13512 (gabapentin enacarbil) to February 9, 2010. The original PDUFA date for this NDA review was November 9, 2009. [More]

Free electronic TBI screenings for veterans

6. November 2009 03:31
With Veterans Day approaching on November 11, our thoughts turn to supporting our veterans. Hospital for Special Care (HSC) is offering screenings for the effects of Traumatic Brain Injury (TBI) in veterans returning from service in Iraq and Afghanistan. HSC is an extensive resource to veterans and their families on the education and treatment of TBI. [More]

Boosting NAD+ after spinal cord injury may prevent permanent nerve death

6. November 2009 02:10
Substances naturally produced by the human body may one day help prevent paralysis following a spinal cord injury, according to researchers at Weill Cornell Medical College. A recent $2.5 million grant from the New York State Spinal Cord Injury Research Board will fund their research investigating this possibility. [More]

Stem cell therapy raises hope for autoimmune hearing loss

4. November 2009 07:09
RNL BIO Co., Ltd, a leading biopharmaceutical company specialized in adult stem cell therapeutics announced today that it treated an American college student who was suffering from autoimmune hearing loss and she gained her hearing back in two months after treatment. [More]

Acorda Therapeutics' financial results for the third quarter of 2009 and update on Fampridine-SR

3. November 2009 06:58
Acorda Therapeutics, Inc. today announced its financial results for the third quarter of 2009. [More]

Geron plans to advance clinical program for spinal cord injury

31. October 2009 01:17
Geron Corporation today announced the company’s plan to advance clinical development of its human embryonic stem cell (hESC)-based product, GRNOPC1, for the treatment of spinal cord injury. [More]

CIRM awards Salk Institute $10.8M grant to develop stem-cell based therapy for Lou Gehrig's Disease

29. October 2009 04:20
The Salk Institute has been awarded a $10.8 million grant by the California Institute for Regenerative Medicine (CIRM) for translational research focusing on developing a novel stem-cell based therapy for Amyotrophic Lateral Sclerosis (ALS) - or Lou Gehrig's Disease. [More]

Regeneration of central nervous system axons can be achieved: Study

29. October 2009 04:07
Scientists at the University of California, San Diego School of Medicine report that regeneration of central nervous system axons can be achieved in rats even when treatment delayed is more than a year after the original spinal cord injury. [More]

Posted in: Medical Science News

Tags: , , , , , ,

Enzyme Mst3b is essential for regenerating damaged axons in live animal model, say researchers

26. October 2009 04:13
Researchers at Children's Hospital Boston report that an enzyme known as Mst3b, previously identified in their lab, is essential for regenerating damaged axons (nerve fibers) in a live animal model, in both the peripheral and central nervous systems. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.